Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
- Authors
- Alexander J. MullerJames B. DuHadawayPreston S. DonoverErika Sutanto‐WardGeorge C. Prendergast
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm1196 →Countries where authors are citing Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
This map shows the geographic impact of Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy more than expected).
Fields of papers citing Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
This network shows the impact of Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
About Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
This paper, published in 2005, received 873 indexed citations . Written by Alexander J. Muller, James B. DuHadaway, Preston S. Donover, Erika Sutanto‐Ward and George C. Prendergast covering the research area of Molecular Biology, Psychiatry and Mental health and Biological Psychiatry. It is primarily cited by scholars working on Biological Psychiatry (542 citations), Immunology (329 citations) and Molecular Biology (257 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm1196.